345 related articles for article (PubMed ID: 10989189)
1. Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors.
Zermati Y; Fichelson S; Valensi F; Freyssinier JM; Rouyer-Fessard P; Cramer E; Guichard J; Varet B; Hermine O
Exp Hematol; 2000 Aug; 28(8):885-94. PubMed ID: 10989189
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta1 drives and accelerates erythroid differentiation in the epo-dependent UT-7 cell line even in the absence of erythropoietin.
Zermati Y; Varet B; Hermine O
Exp Hematol; 2000 Mar; 28(3):256-66. PubMed ID: 10720690
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 is an inducer of erythroid differentiation.
Krystal G; Lam V; Dragowska W; Takahashi C; Appel J; Gontier A; Jenkins A; Lam H; Quon L; Lansdorp P
J Exp Med; 1994 Sep; 180(3):851-60. PubMed ID: 7520475
[TBL] [Abstract][Full Text] [Related]
6. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells.
Myklebust JH; Blomhoff HK; Rusten LS; Stokke T; Smeland EB
Exp Hematol; 2002 Sep; 30(9):990-1000. PubMed ID: 12225790
[TBL] [Abstract][Full Text] [Related]
7. In vitro expansion of human cord blood CD36+ erythroid progenitors: temporal changes in gene and protein expression.
Scicchitano MS; McFarland DC; Tierney LA; Narayanan PK; Schwartz LW
Exp Hematol; 2003 Sep; 31(9):760-9. PubMed ID: 12962721
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha inhibits generation of glycophorin A+ cells by CD34+ cells.
Xiao W; Koizumi K; Nishio M; Endo T; Osawa M; Fujimoto K; Sato I; Sakai T; Koike T; Sawada Ki
Exp Hematol; 2002 Nov; 30(11):1238-47. PubMed ID: 12423676
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte-macrophage colony-stimulating factor-dependent growth and erythropoietin-induced differentiation of a human cell line MB-02.
Morgan DA; Gumucio DL; Brodsky I
Blood; 1991 Dec; 78(11):2860-71. PubMed ID: 1954374
[TBL] [Abstract][Full Text] [Related]
10. In vitro proliferation and differentiation of erythroid progenitors of cord blood.
Sakatoku H; Inoue S
Stem Cells; 1997; 15(4):268-74. PubMed ID: 9253110
[TBL] [Abstract][Full Text] [Related]
11. IL-3-dependent early erythropoiesis is stimulated by autocrine transforming growth factor beta.
Böhmer RM
Stem Cells; 2004; 22(2):216-24. PubMed ID: 14990860
[TBL] [Abstract][Full Text] [Related]
12. [Erythropoiesis: a paradigm for the role of caspases in cell death and differentiation].
Ribeil JA; Zermati Y; Vandekerckhove J; Dussiot M; Kersual J; Hermine O
J Soc Biol; 2005; 199(3):219-31. PubMed ID: 16471262
[TBL] [Abstract][Full Text] [Related]
13. A small-scale serum-free liquid cell culture model of erythropoiesis to assess the effects of exogenous factors.
Cheung JO; Casals-Pascual C; Roberts DJ; Watt SM
J Immunol Methods; 2007 Jan; 319(1-2):104-17. PubMed ID: 17174973
[TBL] [Abstract][Full Text] [Related]
14. A novel way to induce erythroid progenitor self renewal: cooperation of c-Kit with the erythropoietin receptor.
Wessely O; Bauer A; Quang CT; Deiner EM; von Lindern M; Mellitzer G; Steinlein P; Ghysdael J; Beug H
Biol Chem; 1999 Feb; 380(2):187-202. PubMed ID: 10195426
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha-induced apoptosis in human erythroid progenitors.
Tarumi T; Sawada K; Sato N; Kobayashi S; Takano H; Yasukouchi T; Takashashi T; Sekiguchi S; Koike T
Exp Hematol; 1995 Nov; 23(12):1310-8. PubMed ID: 7589287
[TBL] [Abstract][Full Text] [Related]
16. CD34+/CD36- cells from myelodysplasia patients have a limited capacity to proliferate but can differentiate in response to Epo and MGF stimulation.
Brada SJ; de Wolf JT; Hendriks DW; Smit JW; Vellenga E
Leukemia; 1998 Jun; 12(6):882-6. PubMed ID: 9639415
[TBL] [Abstract][Full Text] [Related]
17. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.
Sato T; Maekawa T; Watanabe S; Tsuji K; Nakahata T
J Clin Invest; 2000 Jul; 106(2):263-70. PubMed ID: 10903342
[TBL] [Abstract][Full Text] [Related]
18. Transitional change of colony stimulating factor requirements for erythroid progenitors.
Sawada K; Krantz SB; Dai CH; Sato N; Ieko M; Sakurama S; Yasukouchi T; Nakagawa S
J Cell Physiol; 1991 Oct; 149(1):1-8. PubMed ID: 1719002
[TBL] [Abstract][Full Text] [Related]
19. A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cells.
Bhanu NV; Trice TA; Lee YT; Gantt NM; Oneal P; Schwartz JD; Noel P; Miller JL
Blood; 2005 Jan; 105(1):387-93. PubMed ID: 15367428
[TBL] [Abstract][Full Text] [Related]
20. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
